Survivability of transitional cell carcinoma (TCC) is greater when cancer is found early and treatment is initiated. The survival rate depends on the progression of the cancer - whether the cancer cells are localized, have spread into the muscles, entered the surrounding tissues and the major organs, lymph nodes, and bloodstream are thus compromised. Time, size, and area are vital indicators that determine the treatment outcome.
Follow-up care is mandatory after the cancer cells are removed through surgery, advanced procedures and/or radiation therapy. It may be possible that TCC will return in the urinary system, especially in bladder cancer cases.
The prognosis for a patient with TCC varies from one patient to the next, depending on the stage of the cancer. The following percentages show the survivability of TCC based on examples of urinary cancer statistics:
- Early detection has a 5-year survival rate of 85 percent.
- 50 percent of urinary cancer cases found in Stage III are curable
- Urinary cancer that continued 2-years after diagnosis has a 5 percent survival rate.
- One-third of urinary cancer cases go undiagnosed until the cancer has spread beyond the point of origin, making prognosis a growing concern among TCC members that may have developed kidney, colon, stomach, and other types of cancers, or terminal cancer such as pancreatic, liver, and lung cancer.